Advertisement

Inpharma Weekly

, Volume 1641, Issue 1, pp 15–15 | Cite as

VEGF + EGFR = no extra benefit

Clinical study
  • 4 Downloads

Keywords

Vascular Endothelial Growth Factor Epidermal Growth Factor Receptor Bevacizumab Oxaliplatin Capecitabine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2008

Personalised recommendations